Cargando…

Frequency of Continuous Renal Replacement Therapy Use Early in Coronavirus Disease 2019 Pandemic

OBJECTIVES: A subset of patients with coronavirus disease 2019 develop renal failure and require continuous renal replacement therapy. We reviewed the available literature to understand the frequency of continuous renal replacement therapy use among patients with coronavirus disease 2019 who require...

Descripción completa

Detalles Bibliográficos
Autores principales: Baduashvili, Amiran, Oberle, Lauren P., Devitt, Jessica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7259565/
https://www.ncbi.nlm.nih.gov/pubmed/32671352
http://dx.doi.org/10.1097/CCE.0000000000000129
_version_ 1783540156142190592
author Baduashvili, Amiran
Oberle, Lauren P.
Devitt, Jessica
author_facet Baduashvili, Amiran
Oberle, Lauren P.
Devitt, Jessica
author_sort Baduashvili, Amiran
collection PubMed
description OBJECTIVES: A subset of patients with coronavirus disease 2019 develop renal failure and require continuous renal replacement therapy. We reviewed the available literature to understand the frequency of continuous renal replacement therapy use among patients with coronavirus disease 2019 who required intensive care. DATA SOURCES: The authors reviewed PubMed and Google Scholar for published studies and MedRxiv.com for unpublished studies. STUDY SELECTION: Observational and randomized studies that report the frequency of continuous renal replacement therapy use in adult patients with coronavirus disease 2019. DATA EXTRACTION: Data from the eligible studies were extracted independently by two authors into Microsoft Excel. DATA SYNTHESIS: We identified 12 eligible studies (eight published, four unpublished). We found that up to 20% of patients admitted to ICUs may require continuous renal replacement therapy. CONCLUSIONS: Given the high utilization of continuous renal replacement therapy by critically ill patients with coronavirus disease 2019, there may be an urgent need to mobilize inpatient dialysis resources to cope with the anticipated increase in the demand.
format Online
Article
Text
id pubmed-7259565
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-72595652020-07-14 Frequency of Continuous Renal Replacement Therapy Use Early in Coronavirus Disease 2019 Pandemic Baduashvili, Amiran Oberle, Lauren P. Devitt, Jessica Crit Care Explor Brief Report OBJECTIVES: A subset of patients with coronavirus disease 2019 develop renal failure and require continuous renal replacement therapy. We reviewed the available literature to understand the frequency of continuous renal replacement therapy use among patients with coronavirus disease 2019 who required intensive care. DATA SOURCES: The authors reviewed PubMed and Google Scholar for published studies and MedRxiv.com for unpublished studies. STUDY SELECTION: Observational and randomized studies that report the frequency of continuous renal replacement therapy use in adult patients with coronavirus disease 2019. DATA EXTRACTION: Data from the eligible studies were extracted independently by two authors into Microsoft Excel. DATA SYNTHESIS: We identified 12 eligible studies (eight published, four unpublished). We found that up to 20% of patients admitted to ICUs may require continuous renal replacement therapy. CONCLUSIONS: Given the high utilization of continuous renal replacement therapy by critically ill patients with coronavirus disease 2019, there may be an urgent need to mobilize inpatient dialysis resources to cope with the anticipated increase in the demand. Wolters Kluwer Health 2020-05-14 /pmc/articles/PMC7259565/ /pubmed/32671352 http://dx.doi.org/10.1097/CCE.0000000000000129 Text en Copyright © 2020 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
spellingShingle Brief Report
Baduashvili, Amiran
Oberle, Lauren P.
Devitt, Jessica
Frequency of Continuous Renal Replacement Therapy Use Early in Coronavirus Disease 2019 Pandemic
title Frequency of Continuous Renal Replacement Therapy Use Early in Coronavirus Disease 2019 Pandemic
title_full Frequency of Continuous Renal Replacement Therapy Use Early in Coronavirus Disease 2019 Pandemic
title_fullStr Frequency of Continuous Renal Replacement Therapy Use Early in Coronavirus Disease 2019 Pandemic
title_full_unstemmed Frequency of Continuous Renal Replacement Therapy Use Early in Coronavirus Disease 2019 Pandemic
title_short Frequency of Continuous Renal Replacement Therapy Use Early in Coronavirus Disease 2019 Pandemic
title_sort frequency of continuous renal replacement therapy use early in coronavirus disease 2019 pandemic
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7259565/
https://www.ncbi.nlm.nih.gov/pubmed/32671352
http://dx.doi.org/10.1097/CCE.0000000000000129
work_keys_str_mv AT baduashviliamiran frequencyofcontinuousrenalreplacementtherapyuseearlyincoronavirusdisease2019pandemic
AT oberlelaurenp frequencyofcontinuousrenalreplacementtherapyuseearlyincoronavirusdisease2019pandemic
AT devittjessica frequencyofcontinuousrenalreplacementtherapyuseearlyincoronavirusdisease2019pandemic